![]() An 8-week interval between the first and second primary series doses might be optimal for some people ages 6 months–64 years, especially for males ages 12–39 years, as it might reduce the small risk of myocarditis and pericarditis associated with this vaccine. ![]() The primary series doses are separated by 3–8 weeks. A 2-dose primary series to people ages 12 years and older.The Novavax* COVID-19 vaccine is authorized to provide: Have the option to receive 1 additional bivalent mRNA vaccine dose at least 4 months after the first dose of a bivalent mRNA vaccine. Most people ages 6 years and older who are not moderately or severely immunocompromised and have received 1 dose of a bivalent mRNA vaccine do not need any further vaccine doses at this time. People ages 65 years and older who received 1 dose of a bivalent vaccine have the option to receive 1 additional dose at least 4 months after the first bivalent dose.ĬOVID-19 Vaccination for Individuals NOT Previously Vaccinated People ages 12 years and older who previously received 1 or 2 monovalent Novavax COVID-19 primary series dose(s) are recommended to receive 1 bivalent mRNA vaccine dose. People who previously received a bivalent mRNA vaccine dose(s) have the option to receive 1 or more additional bivalent mRNA doses.People ages 6 months and older who previously received only monovalent doses are recommended to receive 1 or 2 bivalent mRNA vaccine doses, depending on age and vaccine product.At the time of initial vaccination, people ages 6 months and older are recommended to receive 3 bivalent mRNA doses.People ages 65 years and older have the option to receive 1 additional bivalent mRNA vaccine doseįor people who are moderately or severely immunocompromised:.People ages 6 years and older who are unvaccinated or previously received only monovalent vaccine doses are recommended to receive 1 bivalent mRNA vaccine dose.At the time of initial vaccination, depending on vaccine product, children ages 6 months–4 years are recommended to receive 2 or 3 bivalent mRNA vaccine doses children age 5 years are recommended to receive 1 or 2 bivalent mRNA vaccine doses.The number of bivalent doses varies by age, vaccine, previous COVID-19 vaccines received, and the presence of moderate or severe immune compromise.įor people who are not moderately or severely immunocompromised: Overview of the COVID-19 vaccination scheduleĬDC recommends that people ages 6 months and older receive at least 1 bivalent mRNA COVID-19 vaccine.Īn overview of COVID-19 vaccination is summarized below. ![]() See Appendices A ( People who received COVID-19 vaccine outside the United States) and B ( People who received COVID-19 vaccine as part of a clinical trial) for recommendations for these populations. CDC recommends that people stay up to date with COVID-19 vaccination. There is currently no FDA-authorized COVID-19 vaccine for children younger than age 6 months. View the Upcoming Clinic Schedule Groups recommended for vaccinationĬOVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. The Niagara County Department of Health will continue to offer FREE COVID-19 vaccine at several sites.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |